Roobol C, De Dobbeleer G B, Bernheim J L
Br J Cancer. 1984 Jun;49(6):739-44. doi: 10.1038/bjc.1984.116.
The mode of action of 5-fluorouracil (FUra) and 5-fluoro-2'-deoxyuridine (FdUrd) on L1210 leukaemia has been studied. It is shown that FUra and FdUrd follow different routes of metabolism and have different targets with respect to their cytotoxic activity. FUra is converted to 5-fluorouridine-5'triphosphate ( FUTP ), which is incorporated into nascent RNA. FdUrd is converted to 5-fluoro-2'-deoxyuridine-5'-monophosphate (FdUMP), which inhibits the de novo synthesis of 2'-deoxythymidine-5'-monophosphate (dTMP). Conversion of FUra to FdUMP does occur, but this phenomenon does not contribute to the final cytotoxic effect. No conversion of FdUrd to FUra has been detected.
对5-氟尿嘧啶(FUra)和5-氟-2'-脱氧尿苷(FdUrd)作用于L1210白血病的作用方式进行了研究。结果表明,FUra和FdUrd在代谢途径和细胞毒性活性靶点方面存在差异。FUra转化为5-氟尿苷-5'-三磷酸(FUTP),并掺入新生RNA中。FdUrd转化为5-氟-2'-脱氧尿苷-5'-单磷酸(FdUMP),它抑制2'-脱氧胸苷-5'-单磷酸(dTMP)的从头合成。FUra确实会转化为FdUMP,但这种现象对最终的细胞毒性作用没有贡献。未检测到FdUrd转化为FUra。